SCHEMBL2222934

SCHEMBL2222934

CCCOc1cc[c]c(-c2ccc(OCC)cc2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 1/20 0.42
CYP1A2 P05177 3/20 0.40
CYP19A1 P11511 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
CYP2D6 P10635 2/20 0.40
GAA P10253 2/20 0.39
SMN1; SMN2 Q16637 6/20 0.39
ALDH1A1 P00352 6/20 0.39
KDM4E B2RXH2 5/20 0.39
LTA4H P09960 1/20 0.39
FFAR1 O14842 2/20 0.39
FFAR4 Q5NUL3 2/20 0.39
RAB9A P51151 6/20 0.38
NPC1 O15118 5/20 0.38
HPGD P15428 3/20 0.38
HSD17B10 Q99714 3/20 0.38
MAPT P10636 2/20 0.38
ALOX12 P18054 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8532102 0.92 NQO1 (0.50) NQO1CYP1A2CYP19A1CYP2C9CYP2C19
SCHEMBL8007736 0.86 CYP19A1 (0.48) CYP1A2CYP19A1CYP2C9CYP2C19CYP2D6
SCHEMBL7078066 0.85 LTA4H (0.50) GAAALDH1A1LTA4HRAB9ANPC1
SCHEMBL9783835 0.85 NR5A1 (0.50) CYP1A2CYP19A1CYP2C9CYP2C19CYP2D6
SCHEMBL8527534 0.84 NQO1 (0.45) NQO1GAASMN1; SMN2ALDH1A1KDM4E
SCHEMBL6382918 0.84 CYP11B1 (0.44) NQO1GAASMN1; SMN2ALDH1A1KDM4E
SCHEMBL8187884 0.84 ALDH1A1 (0.39) CYP1A2CYP19A1CYP2C9CYP2C19CYP2D6
SCHEMBL15066586 0.84 KMT2A (0.42) KDM4ELTA4HMAPTL3MBTL1TSHR
SCHEMBL17536735 0.83 MAPT (0.39) NQO1CYP19A1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL9700067 0.82 CYP2D6 (0.49) CYP1A2CYP19A1CYP2C9CYP2C19CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011084503-A1 PHENOXY THIOPHENE SULFONAMIDES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES NORTH CAROLINA CENTRAL UNIVERSITY (US) 2011-07-14 WO claimed